← Back to headlines
Eli Lilly's Taltz-Zepbound Combo Shows Breakthrough in Psoriasis-Obesity Trial
Eli Lilly has announced a landmark trial demonstrating a major breakthrough with its Taltz-Zepbound drug combination for treating both psoriasis and obesity.
21 Feb, 17:31 — 21 Feb, 17:31
Sources
Showing 1 of 1 sources
Related Stories
Dutch Health Agency Warns of Potentially Fatal Trump-Shaped Ecstasy Pills
36m ago
48-Year-Old Anesthesiologist Found Dead in Greek Hospital On-Call Room
2h ago
Art World Mourns Yayoi Kusama as Tributes Highlight Her Lasting Creative Legacy
3h ago
Study Reveals Hidden Arterial Calcification in Young Adults
4h ago